Immunoadsorption as a novel therapy for refractory idiopathic
inflammatory myopathies: a retrospective observational study.
Kastrati K, Karonitsch T, Rajab H, Reindl-Schwaighofer R, Eskandary F,
Pajenda S, Mrak D, Heil PM, Kiener HP, Bonelli M, Derfler K, Aletaha
D, Smolen JS, Radner H. Rheumatology (Oxford). 2025;64:5304-5312.
Systemic correlates of cutaneous manifestations of lupus
erythematosus
Peter M. Heil, Mark R. Pittelkow, Amy L. Weaver, Jill M. Killian,
Olayemi Sokumbi, David A. Wetter. Int J Dermatol 2024;63:e148-e156.
Impact of muscle biopsy on the clinical decision-making process in
patients with suspected idiopathic inflammatory myopathy
Kastriot Kastrati, Nasim Nakhost Lotfi, Marwa G Tawfik , Ellen Gelpi ,
Simon Hametner , Romana Höftberger 3, Fritz Zimprich , Hakan Cetin,
Elisabeth Lindeck-Pozza , Peter Maximilian Heil, Hans P Kiener ,
Leonhard X Heinz , Daniel Mrak , Daniel Aletaha , Michael Bonelli ,
Helga Radner J Autoimmun. 2024 Apr:144:103185.
PM/Scl-Overlap-Syndrom bei einem 14-jährigen Mädchen nach
SARS-CoV-2-Infektion.
Dadak L, Heil PM, Geleff S, Prosch H, Idzko M, Hojreh A, Szepfalusi Z,
Valent I, Emminger W. J Dtsch Dermatol Ges. 2023;21:661-663.
COVID-19 as a putative trigger of anti-MDA5-associated dermatomyositis
with acute respiratory distress syndrome (ARDS) requiring lung
transplantation, a case report.
Anderle K, Machold K, Kiener HP, Bormann D, Hoetzenecker K, Geleff S,
Prosch H, Laccone F, Heil PM, Petzelbauer P, Aletaha D, Blüml S,
Kastrati K. BMC Rheumatol. 2022 13;6:42.
Cutaneous ulceration as primary presentation of TEMPI syndrome.
Strobl J, Sinz C, Heil PM, Stary G, Weninger W. J Eur Acad Dermatol
Venereol. 2021 Dec;35:e891-e894.
Specific Inhibition of the Classical Complement Pathway Prevents C3
Deposition along the Dermal-Epidermal Junction in Bullous
Pemphigoid.
Freire PC, Muñoz CH, Derhaschnig U, Schoergenhofer C, Firbas C, Parry
GC, Panicker S, Gilbert JC, Stingl G, Jilma B, Heil PM. J Invest
Dermatol. 2019;139:2417-2424.
Type IV Allergy to Antimalarials Can Mimic Cutaneous Manifestations of
Lupus Erythematosus.
Borik L, Petzelbauer P, Quint T, Wöhrl S, Kinaciyan T, Heil PM
J Eur Acad Dermatol Venereol 2019;33:e94-e96.
Influence of smoking on disease severity and antimalarial therapy in
cutaneous lupus erythematosus: analysis of 1002 patients from the
EUSCLE database
Kuhn A, Biazar C, Ruland V, Patsinakidis N, Landmann A, Amler S,
Bonsmann G, the EUSCLE coauthors 1). Br J Dermatol 2014;171:571-9.
Therapeutic strategies evaluated by the European Society of Cutaneous
Lupus Erythematosus (EUSCLE) Core Set Questionnaire in more than 1000
patients with cutaneous lupus erythematosus.
Sigges J, Biazar C, Landmann A, Ruland V, Patsinakidis N, Amler S,
Bonsmann G, Kuhn A; EUSCLE co-author 1) Autoimmun Rev.
2013;12:694-702.
Cutaneous lupus erythematosus: First multicenter database analysis of
1002 patientsfrom the European Society of Cutaneous Lupus
Erythematosus (EUSCLE) Cyrus Biazara, Johanna Siggesa, Nikolaos
Patsinakidisa, Vincent Rulanda, Susanne Amlerb,Gisela Bonsmanna,
Annegret Kuhna and the EUSCLE co-author 1)
Autoimmunity Reviews 2013; 444-454.
The risk of infections in HIV-HCV coinfected patients during antiviral
therapy with pegIFN+RBV.
Payer BA, Reiberger T, Breitenecker F, Aichelburg MC, Schuster C, Heil
PM, Scherzer TM, Ferenci P, Rieger A, Peck-Radosavljevic M; Vienna HIV
& Liver Study Group. J Infect. 2012;65:142-9.
Concomitant highly active antiretroviral therapy leads to smaller
decline and faster recovery of CD4+ cell counts during and after
pegylated interferon plus ribavirin therapy in HIV-hepatitis C virus
coinfected patients.
Reiberger T, Payer BA, Kosi L, Heil PM, Rieger A, Peck-Radosavljevic
M; Vienna HIV Coinfection Study Group. J Infect Dis. 2011;203:1802-6.
Omalizumab therapy in atopic dermatitis: depletion of IgE does not
improve the clinical course - a randomized, placebo-controlled and
double blind pilot study.
Heil PM, Maurer D, Klein B, Hultsch T, Stingl G.
J Dtsch Dermatol Ges. 2010; 8:990-8
Transglutaminases as diagnostically relevant autoantigens in patients
with gluten sensitivity.
Heil PM, Volc-Platzer B, Karlhofer F, Gebhart W, Huber WD, Benesch T,
Vogelsang H, Stingl G.
J Dtsch Dermatol Ges. 2005;3:974-8.
EUSCLE co-authors: M. Haust, Department of Dermatology, University of Duesseldorf, Duesseldorf, Germany; F. Nyberg, Department of Dermatology, University of Uppsala,Uppsala, Sweden; Z. Bata, L. Mihályi, Department of Dermatology, University of Szeged, Szeged, Hungary; R. Olteanu, Colentia Hospital, Dermatology, Bucharest, Romania;R.M. Pujol, J.M. Sánchez-Schmidt, Department of Dermatology, Parc de Salut Mar-IMAS, Barcelona, Spain; L. Medenica, D. Skiljevic, Department of Dermatovenereology, Schoolof Medicine, University of Belgrade, Clinic of Dermatovenereology, Clinical Center of Serbia, Belgrade, Serbia; A. Reich, J.C. Szepietowski, Department of Dermatology, Venerologyand Allergology, Wroclaw Medical University, Wroclaw, Poland; C. Dalle Vedove, G. Girolomoni, Department of Dermatology, University of Verona, Verona, Italy; T. Hawro,A. Zalewska-Janowska, Psychodermatology Department, Clinical Immunology and Microbiology, Medical University of Lodz, Lodz, Poland (the study was conducted at the Depart-ment of Dermatology and Venereology, Medical University of Lodz, Lodz, Poland); R. Glaeser, R. Huegel, Department of Dermatology of the University Hospital ofSchleswig-Holstein, Campus Kiel, Kiel, Germany; H. Jedličková, Department of Dermatology, St. Anna University Hospital, Brno, Czech Republic; A. Bygum, R. Laurinaviciene, Depart-ment of Dermatology and Allergy Center, Odense University Hospital, Odense C, Denmark; S. Benoit, E. Broecker, Department of Dermatology, Venerology and Allergology, Univer-sity Hospital Wuerzburg, Wuerzburg, Germany; F.A. Bahmer, Department of Dermatology, Hospital Bremen-Mitte, Bremen, Germany; E. Aberer, N. Wutte, Department ofDermatology, Medical University Graz, Graz, Austria; J. Lipozencic, B. Marinovic, University Hospital Center Zagreb, Department of Dermatology and Venerology, School of MedicineUniversity of Zagreb, Zagreb, Croatia; M. Sárdy, V. Bekou, T. Ruzicka, Department of Dermatology and Allergology, Ludwig Maximilian University, Munich, Germany; C. Frances, B.Soutou, Tenon Hospital, Department of Dermatology, Paris, France; H. Lee, M. Worm, Department of Dermatology and Allergy, Charité Campus Mitte, Universitaetsmedizin Berlin,Berlin, Germany; A. Gruschke, N. Hunzelmann, Department of Dermatology and Venerology, University Hospital Cologne, Cologne, Germany; K. Steinbrink, Department of Derma-tology, University Medical Center Mainz, Mainz, Germany; R. Romiti, Department of Dermatology, University of Sao Paulo, Sao Paulo, Brazil; M. Sticherling, C. Erfurt-Berge, Depart-ment of Dermatology, University Erlangen, Erlangen, Germany; G. Avgerinou, D. Papafragkaki, Department of Dermatology, University of Athens, A. Sygros Hospital, Athens, Greece;E. Antiga, M. Caproni, Department of Dermatology Sciences, University of Florence, Florence, Italy; B. Mayer, B. Volc-Platzer, Department of Dermatology, Donauspital Wien, Vienna,Austria; A. Kreuter, C. Tigges, Department of Dermatology, Venereology and Allergology, Ruhr University Bochum, Bochum, Germany; P.M. Heil, G. Stingl, Division of Immunology,Allergy and Infectious Diseases, Department of Dermatology, Medical University Vienna, Vienna, Austria.